Risk factors for falls in patients treated with chemotherapy
Chemotherapy was identified as an independent risk factor for falls. Among patients receiving chemotherapy, both hypoglycemic drugs and high-risk CIPN drugs were associated with an increased risk of falls, and the fall rate was significantly higher in those treated with both drugs. Therefore, these patients should be carefully monitored for fall risk.
Authors
- Takashi Otsuka (ORCID: https://orcid.org/0000-0002-7892-441X)
- Kenshi Takechi (ORCID: https://orcid.org/0000-0002-9376-2703)
- Shingo Takatori (ORCID: https://orcid.org/0000-0002-5498-0564)
- Chiyuki Tsukui
- Satoru Hirai
- Shinji Oda
Institutions
- Matsuyama University (JP)
- Matsuyama Shimin Hospital (JP)
Publication Details
- Journal
- Journal of Pharmaceutical Health Care and Sciences
- Published
- 2025-10-27
- DOI
- https://doi.org/10.1186/s40780-025-00502-w
- Primary Topic
- Cancer Treatment and Pharmacology
- Type
- article
- Field-Weighted Citation Impact
- 0.00